Type / Class
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Shares outstanding
239,647,920
Total 13F shares
47,893,528
Share change
-4,544,850
Total reported value
$4,559,336,247
Put/Call ratio
108%
Price per share
$95.20
Number of holders
282
Value change
-$440,520,029
Number of buys
135
Number of sells
111

Quarterly Holders Quick Answers

What is CUSIP 09075V102?
CUSIP 09075V102 identifies BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q4 2025

As of 31 Dec 2025, BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by 282 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,893,528 shares. The largest 10 holders included FMR LLC, T. Rowe Price Investment Management, Inc., FLOSSBACH VON STORCH SE, PRIMECAP MANAGEMENT CO/CA/, Dodge & Cox, BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd, JANE STREET GROUP, LLC, BAILLIE GIFFORD & CO, and BlackRock, Inc.. This page lists 282 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.